Literature DB >> 23740450

Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice.

W Tripanichkul1, E-O Jaroensuppaperch.   

Abstract

BACKGROUND: Inflammation and oxidative stress are believed to contribute to neuronal degeneration of the nigrostriatal dopaminergic (DA) pathway in Parkinson's disease. Curcumin, a component of the yellow curry spice, has been reported possessing anti-inflammatory and anti-oxidative effects. AIM: The present study investigated the effects of curcumin on the extent of DA innervation, glial response, and Cu/Zn superoxide dismutase (SOD1) expression in the striatum of 6-hydroxydopamine (6-OHDA)-lesioned mice.
MATERIALS AND METHODS: 6-OHDA was unilaterally injected into the right striatum of ICR male mice. Curcumin (200 mg/kg) was administered daily for 7 days starting instantaneously after 6-OHDA injection. Seven days after 6-OHDA insult, mice were euthanized and striatal sections were collected, immunohistochemically stained, and quantitated for tyrosine hydroxylase (TH), glial fibrillary acidic protein (GFAP), ionized calcium binding adapter molecule 1 (Iba1), and SOD1 immunoreactivity.
RESULTS: 6-OHDA injection triggered a significant loss of TH-immunoreactive (-IR) axons, induced reaction of GFAP-IR astrocytes and Iba1-IR microglia, and decreased SOD1 expression in the 6-OHDA-lesioned striatum. Curcumin attenuated loss of TH-IR fibers, diminished activation of astrocytes and microglia, and sustained SOD1 level in the lesioned striatum.
CONCLUSIONS: These results suggest that curcumin counteracts the neurotoxicity of 6-OHDA through its anti-inflammatory properties (inhibition of glial response) and preservation of SOD1 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740450

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  17 in total

Review 1.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

2.  Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.

Authors:  Jeyapriya Raja Sundaram; Charlene Priscilla Poore; Noor Hazim Bin Sulaimee; Tej Pareek; Wei Fun Cheong; Markus R Wenk; Harish C Pant; Sally A Frautschy; Chian-Ming Low; Sashi Kesavapany
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Impact of partial dopamine depletion on cognitive flexibility in BDNF heterozygous mice.

Authors:  Vinay Parikh; Sean X Naughton; Brittney Yegla; Dawn M Guzman
Journal:  Psychopharmacology (Berl)       Date:  2016-02-10       Impact factor: 4.530

Review 4.  Plant-derived neuroprotective agents in Parkinson's disease.

Authors:  Wenyu Fu; Wenxin Zhuang; Shuanhu Zhou; Xin Wang
Journal:  Am J Transl Res       Date:  2015-07-15       Impact factor: 4.060

5.  Protective Effect of Curcumin by Modulating BDNF/DARPP32/CREB in Arsenic-Induced Alterations in Dopaminergic Signaling in Rat Corpus Striatum.

Authors:  Pranay Srivastava; Yogesh K Dhuriya; Richa Gupta; Rajendra K Shukla; Rajesh S Yadav; Hari N Dwivedi; Aditya B Pant; Vinay K Khanna
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

Review 6.  NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols.

Authors:  Saumitra Sen Singh; Sachchida Nand Rai; Hareram Birla; Walia Zahra; Aaina Singh Rathore; Surya Pratap Singh
Journal:  Neurotox Res       Date:  2019-12-10       Impact factor: 3.911

Review 7.  Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review.

Authors:  Xin-Shi Wang; Zeng-Rui Zhang; Man-Man Zhang; Miao-Xuan Sun; Wen-Wen Wang; Cheng-Long Xie
Journal:  BMC Complement Altern Med       Date:  2017-08-17       Impact factor: 3.659

8.  Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease.

Authors:  Irene Paterniti; Michela Campolo; Rosalba Siracusa; Marika Cordaro; Rosanna Di Paola; Vittorio Calabrese; Michele Navarra; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

9.  Liposomal Encapsulated Curcumin Effectively Attenuates Neuroinflammatory and Reactive Astrogliosis Reactions in Glia Cells and Organotypic Brain Slices.

Authors:  Christina Schmitt; Anna Lechanteur; François Cossais; Coralie Bellefroid; Philipp Arnold; Ralph Lucius; Janka Held-Feindt; Geraldine Piel; Kirsten Hattermann
Journal:  Int J Nanomedicine       Date:  2020-05-25

10.  Effects of dopamine, norepinephrine and dobutamine on gastric mucosal pH of septic shock patients.

Authors:  Yifen Wu; Ning Zhang; Yifu Wu; Yanping Zheng; Xiaoen You; Zhuo Cao; Yaqi Xu
Journal:  Exp Ther Med       Date:  2016-05-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.